The venous angioarchitecture of sporadic cerebral cavernous malformations: A susceptibility weighted imaging study at 7 T MRI

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 2, 2013, Pages 194-200

  Dammann, Philipp ^a,b   Wrede, Karsten H ^a,b   Maderwald, Stefan ^b   El Hindy, Nicolai ^a   Mueller, Oliver ^a   Chen, Bixia ^a   Zhu, Yuan ^a   Hütter, Bernd Otto ^a   Ladd, Mark E ^a,b   Schlamann, Marc ^a   Erol Sandalcioglu, I ^a   Sure, Ulrich ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CAVERNOUS HEMANGIOMA; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; SEIZURE; SUSCEPTIBILITY WEIGHTED IMAGING; VEIN MALFORMATION;

EID: 84872678880     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302599     Document Type: Article

References (40)

1. Otten P, Pizzolato GP, Rilliet B, et al. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie 1989;35:82-3. 128-31.
2. Li DY, Whitehead KJ. Evaluating strategies for the treatment of cerebral cavernous malformations. Stroke 2010;41(10 Suppl):S92-4.
3. Riant F, Bergametti F, Ayrignac X, et al. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J;277:1070-5.
4. Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988;319:343-7.
5. Yadla S, Jabbour PM, Shenkar R, et al. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus (Rev) 2010;29:E4.
6. Larson JJ, Ball WS, Bove KE, et al. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children. J Neurosurg 1998;88:51-6.
7. Campeau NG, Lane JI. De novo development of a lesion with the appearance of a cavernous malformation adjacent to an existing developmental venous anomaly. Am J Neuroradiol 2005;26:156-9.
8. Perrini P, Lanzino G. The association of venous developmental anomalies and cavernous malformations: pathophysiological, diagnostic, and surgical considerations. Neurosurg Focus 2006;21:e5.
9. Petersen TA, Morrison LA, Schrader RM, et al. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. Am J Neuroradiol 2009;31:377-82.
10. Awad IA, Robinson JR Jr., Mohanty S, et al. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery 1993;33:179-88.
11. Thai Q-A, Pradilla G, Rigamonti D. Capillary telangiectasias, cavernous malformations, and developmental venous anomalies: different expressions of the same disease process? In: Brandenberg B, ed. Cavernous malformations of the brain and spinal cord. New York, NY: Thieme Medical Publishers, Inc., 2008:48-53.
12. Lasjaunias P, Burrows P, Planet C. Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev 1986;9:233-42.
13. Porter RW, Detwiler PW, Spetzler RF, et al. Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg 1999;90:50-8.
14. Kamezawa T, Hamada J, Niiro M, et al. Clinical implications of associated venous drainage in patients with cavernous malformation. J Neurosurg 2005;102:24-8.
15. San Millan Ruiz D, Gailloud P. Cerebral developmental venous anomalies. Childs Nerv Syst 2010;26:1395-406.
16. Santucci GM, Leach JL, Ying J, et al. Brain parenchymal signal abnormalities associated with developmental venous anomalies: detailed MR imaging assessment. Am J Neuroradiol 2008;29:1317-23.
17. Giliberto G, Lanzino DJ, Diehn FE, et al. Brainstem cavernous malformations: anatomical, clinical, and surgical considerations. Neurosurg Focus 2010;29:E9.
18. Mittal S, Wu Z, Neelavalli J, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. Am J Neuroradiol 2009;30:232-52.
19. Haacke EM, Mittal S, Wu Z, et al. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. Am J Neuroradiol 2009;30:19-30.
20. de Champfleur NM, Langlois C, Ankenbrandt WJ, et al. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility- weighted imaging. Neurosurgery 2030;68:641-7.
21. Reichenbach JR, Barth M, Haacke EM, et al. High-resolution MR venography at 3.0 Tesla. J Comput Assisted Tomography 2000;24:949-57.
22. Pinker K, Stavrou I, Szomolanyi P, et al. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings-preliminary results. Invest Radiol 2007;42:346-51.
23. Al-Shahi Salman R, Berg MJ, Morrison L, et al. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke 2008;39:3222-30.
24. Dammann P, Barth M, Zhu Y, et al. Susceptibility weighted magnetic resonance imaging of cerebral cavernous malformations: prospects, drawbacks, and first experience at ultra-high field strength (7-Tesla) magnetic resonance imaging. Neurosurg Focus 2010;29:E5.
25. Landis JR, Koch GGK. The measurement of observer agreement for categorial data. Biometrics 1977;33:159-74.
26. Little JR, Awad IA, Jones SC, et al. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg 1990;73:555-9.
27. Partain CL, Guinto FC, Scatliff JH, et al. Cerebral venous angioma: correlation of radionuclide brain scan, transmission computed tomography, and angiography. J Nucl Med 1979;20:1166-9.
28. Ciricillo SF, Dillon WP, Fink ME, et al. Progression of multiple cryptic vascular malformations associated with anomalous venous drainage. Case Report J Neurosurg 1994;81:477-81.
29. Ruiz DS, Yilmaz H, Gailloud P. Cerebral developmental venous anomalies: current concepts. Ann Neurol 2009;66:271-83.
30. Clatterbuck RE, Moriarity JL, Elmaci I, et al. Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis. J Neurosurg 2000;93:981-6.
31. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422-32.
32. Topper R, Jurgens E, Reul J, et al. Clinical significance of intracranial developmental venous anomalies. J Neurol Neurosurg Psychiatry 1999;67:234-8.
33. Pozzati E, Acciarri N, Tognetti F, et al. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery 1996;38:662-9.
34. Truwit CL. Venous angioma of the brain: history, significance, and imaging findings. AJR Am J Roentgenol 1992;159:1299-307.
35. Hong YJ, Chung TS, Suh SH, et al. The angioarchitectural factors of the cerebral developmental venous anomaly; can they be the causes of concurrent sporadic cavernous malformation? Neuroradiology 2010;52:883-91.
36. Shenkar R, Venkatasubramanian PN, Zhao JC, et al. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions. Neurosurgery 2008;63:782-9.
37. Shenkar R, Venkatasubramanian PN, Wyrwicz AM, et al. Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery 2008;63:790-7.
38. Wang H, Gujrati M. Pathology of cerebral cavernous malformations. In: Brandenberg B, ed. Cavernous malformations of the brain and spinal cord. New York, NY: Thieme Medical Publishers, Inc., 2008:22-5.
39. Wurm G, Schnizer M, Fellner FA. Cerebral cavernous malformations associated with venous anomalies: surgical considerations. Neurosurgery 2005; 57(1 Suppl):42-58.
40. Denier C, Labauge P, Brunereau L, et al. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol 2004;55:213-20.